No association between perfluoroalkyl chemicals and hypertension in children

Integrated Blood Pressure Control

Volumn 7, Issue 1, 2014, Pages 1-7

  Geiger, Sarah Dee ^a   Xiao, Jie ^b   Shankar, Anoop ^c  

^a NORTHERN ILLINOIS UNIVERSITY   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Blood pressure; Children; Perfluoroalkyl chemicals; Perfluorooctane sulfonate; Perfluorooctanoic acid

Indexed keywords

CHOLESTEROL; COTININE; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID;

ADOLESCENT; ARTICLE; BLOOD LEVEL; BODY MASS; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; COTININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; ENVIRONMENTAL EXPOSURE; FEMALE; HISPANIC; HUMAN; HYPERTENSION; MALE; NEGRO; PERFLUOROOCTANESULFONIC ACID BLOOD LEVEL; PERFLUOROOCTANOIC ACID BLOOD LEVEL; POPULATION RESEARCH; SYSTOLIC BLOOD PRESSURE; UNITED STATES;

EID: 84892591911     PISSN: None     EISSN: 11787104     Source Type: Book Series    
DOI: 10.2147/IBPC.S47660     Document Type: Article

References (53)

1. Calafat AM, Wong LY, Kuklenyik Z, Reidy JA, Needham LL. Polyfluoroalkyl chemicals in the US population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ Health Perspect. 2007;115(11):1596-1602.
2. Lau C, Anitole K, Hodes C, Lai D, Pfahles-Hutchens A, Seed J. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci. 2007;99(2):366-394.
3. Steenland K, Fletcher T, Savitz DA. Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA). Environ Health Perspect. 2010;118(8):1100-1108.
4. McNiece KL, Poffenbarger TS, Turner JL et al. Prevalence of hypertension and pre-hypertension among adolescents. J Pediatr. 2007;150(6):640-644.
5. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010;303(20):2043-2050.
6. Heron M, Hoyert DL, Murphy SL, Xu J, Kochanek KD, Tejada-Vera B. Deaths: final data for 2006. Natl Vital Stat Rep. 2009;57(14):1-134.
7. Garrison RJ, Kannel WB, Stokes J III, Castelli WP. Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med. 1987;16(2):235-251.
8. Leitschuh M, Cupples LA, Kannel W, Gagnon D, Chobanian A. High-normal blood pressure progression to hypertension in the Framingham Heart Study. Hypertension. 1991;17(1):22-27.
9. Howard G, Wagenknecht LE, Burke GL, et al. Cigarette smoking and progression of atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. JAMA. 1998;279(2):119-124.
10. Nelson L, Jennings GL, Esler MD, Korner PI. Effect of changing levels of physical activity on blood-pressure and haemodynamics in essential hypertension. Lancet. 1986;2(8505):473-476.
11. Chen Y, Factor-Litvak P, Howe GR, et al. Arsenic exposure from drinking water, dietary intakes of B vitamins and folate, and risk of high blood pressure in Bangladesh: a population-based, cross-sectional study. Am J Epidemiol. 2007;165(5):541-552.
12. Hu H, Aro A, Payton M, et al. The relationship of bone and blood lead to hypertension. The Normative Aging Study. JAMA. 1996;275(15): 1171-1176.
13. Park SK, Mukherjee B, Xia X, et al. Bone lead level prediction models and their application to examine the relationship of lead exposure and hypertension in the Third National Health and Nutrition Examination Survey. J Occup Environ Med. 2009;51(12):1422-1436.
14. Shankar A, Teppala S. Urinary bisphenol A and hypertension in a multiethnic sample of US adults. J Environ Public Health. 2012; 2012:481641.
15. Siddiqui MK, Nigam U, Srivastava S, Tejeshwar DS, Chandrawati. Association of maternal blood pressure and hemoglobin level with organochlorines in human milk. Hum Exp Toxicol. 2002;21(1):1-6.
16. C8 Science Panel. Probable link evaluation of pregnancy induced hypertension and preeclampsia. Available from: http://www.c8sciencepanelorg/pdfs/Probable_Link_C8_pregnancy-induced hypertension_5Dec2011 pdf. Accessed February 1, 2012.
17. Frisbee SJ, Shankar A, Knox SS, et al. Perfluorooctanoic acid, perfluorooctanesulfonate, and serum lipids in children and adolescents: results from the C8 Health Project. Arch Pediatr Adolesc Med. 2010;164(9): 860-869.
18. Shankar A, Xiao J, Ducatman A. Perfluoroalkyl chemicals and elevated serum uric acid in US adults. Clin Epidemiol. 2011;3:251-258.
19. Steenland K, Tinker S, Shankar A, Ducatman A. Association of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) with uric acid among adults with elevated community exposure to PFOA. Environ Health Perspect. 2010;118(2):229-233.
20. Lin CY, Chen PC, Lin YC, Lin LY. Association among serum perfluoroalkyl chemicals, glucose homeostasis, and metabolic syndrome in adolescents and adults. Diabetes Care. 2009;32(4):702-707.
21. Sakr CJ, Leonard RC, Kreckmann KH, Slade MD, Cullen MR. Longitudinal study of serum lipids and liver enzymes in workers with occupational exposure to ammonium perfluorooctanoate. J Occup Environ Med. 2007;49(8):872-879.
22. Sakr CJ, Kreckmann KH, Green JW, Gillies PJ, Reynolds JL, Leonard RC. Cross-sectional study of lipids and liver enzymes related to a serum biomarker of exposure (ammonium perfluorooctanoate or APFO) as part of a general health survey in a cohort of occupationally exposed workers. J Occup Environ Med. 2007;49(10):1086-1096.
23. Olsen GW, Zobel LR. Assessment of lipid, hepatic, and thyroid parameters with serum perfluorooctanoate (PFOA) concentrations in fluorochemical production workers. Int Arch Occup Environ Health. 2007;81(2):231-246.
24. Nelson JW, Hatch EE, Webster TF. Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general US population. Environ Health Perspect. 2010;118(2): 197-202.
25. Shankar A, Li J. Association between serum gamma-glutamyltransferase level and prehypertension among US adults. Circ J. 2007;71(10): 1567-1572.
26. Mazzali M, Hughes J, Kim YG, et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension. 2001;38(5):1101-1106.
27. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109(3):433-438.
28. Sesso HD, Buring JE, Chown MJ, Ridker PM, Gaziano JM. A prospective study of plasma lipid levels and hypertension in women. Arch Intern Med. 2005;165(20):2420-2427.
29. Liu C, Yu K, Shi X, et al. Induction of oxidative stress and apoptosis by PFOS and PFOA in primary cultured hepatocytes of freshwater tilapia (Oreochromis niloticus). Aquat Toxicol. 2007;82(2):135-143.
30. Yao X, Zhong L. Genotoxic risk and oxidative DNA damage in HepG2 cells exposed to perfluorooctanoic acid. Mutat Res. 2005;587(1-2): 38-44.
31. Qian Y, Ducatman A, Ward R, et al. Perfluorooctane sulfonate (PFOS) induces reactive oxygen species (ROS) production in human microvascular endothelial cells: role in endothelial permeability. J Toxicol Environ Health A. 2010;73(12):819-836.
32. Hu W, Jones PD, DeCoen W, et al. Alterations in cell membrane properties caused by perfluorinated compounds. Comp Biochem Physiol C Toxicol Pharmacol. 2003;135(1):77-88.
33. National Center for Health Statistics-CDC. National Health and Nutrition Examination Survey 2003-2004: reference manuals and reports. Available from: http://www.cdcgov/nchs/nhanes/nhanes2003-2004/nhanes03_04.htm. Accessed October 22, 2010.
34. Perloff D, Grim C, Flack J, et al. Human blood pressure determination by sphygmomanometry. Circulation. 1993;88(5 Pt 1):2460-2470.
35. Chobanian AV, Bakris GL, Black HR, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206-1252.
36. National Center for Health Statistics-CDC. Plan and Operation of the Third National Health and Nutrition Examination Survey, 1988-1994. Rockville, MD: US Department of Health and Human Services (Publication 94-1308); 1994. Available from: Plan and Operation of the Third National Health and Nutrition Examination Survey, 1988-1994. Rockville, MD: US Department of Health and Human Services (Publication 94-1308); 1994. Accessed September 26, 2013.
37. Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Pediatrics. 1996;98(4 Pt 1):649-658.
38. Sorof JM, Lai D, Turner J, Poffenbarger T, Portman RJ. Overweight, ethnicity, and the prevalence of hypertension in school-aged children. Pediatrics. 2004;113(3 Pt 1):475-482.
39. National Center for Health Statistics-CDC. Procedures for laboratory components of NHANES. Available from: http://www.cdcgov/nchs/data/nhanes/nhanes_03_04/blood03_04pdf. Accessed October 22, 2010.
40. Hung H-M. Nonlinear regression analysis for complex surveys. Commun Stat Theory Methods. 1990;19(9):3447-3470.
41. Erdman D, Little M. Nonlinear regression analysis and nonlinear simulation models. Cary, NC: SAS Institute Inc. Available from: http://support.sas.com/rnd/app/ets/papers/nonlinearmodels.pdf. Accessed September 25, 2013.
42. National Center for Health Statistics-CDC. Analytical and reporting guidelines for NHANES. Available from: http://www.cdcgov/nchs/data/nhanes/nhanes_03_04/nhanes_analytic_guidelines_dec_2005 pdf. Accessed October 22, 2010.
43. Oparil S, Zaman MA, Calhoun DA. Pathogenesis of hypertension. Ann Intern Med. 2003;139(9):761-776.
44. Carretero OA, Oparil S. Essential hypertension. Part I: definition and etiology. Circulation. 2000;101(3):329-335.
45. Wang W, Lee ET, Fabsitz RR, et al. A longitudinal study of hypertension risk factors and their relation to cardiovascular disease: the Strong Heart Study. Hypertension. 2006;47(3):403-409.
46. Geiger S, Xiao J, Shankar A. Positive association between perfluoroalkyl chemicals and hyperuricemia in children. Am J Epidemiol. 2013; 177(11):1255-1262.
47. Melzer D, Rice N, Depledge MH, et al. Association between serum perfluorooctanoic acid (PFOA) and thyroid disease in the US National Health and Nutrition Examination Survey. Environ Health Perspect. 2010;118(5):686-692.
48. Knox SS, Jackson T, Javins B, et al. Implications of early menopause in women exposed to perfluorocarbons. J Clin Endocrinol Metab. 2011;96(6):1747-1753.
49. Innes KE, Ducatman AM, Luster MI, et al. Association of osteoarthritis with serum levels of the environmental contaminants perfluorooctanoate and perfluorooctane sulfonate in a large Appalachian population. Am J Epidemiol. 2011;174(4):440-450.
50. Seals R, Bartell SM, Steenland K. Accumulation and clearance of perfluorooctanoic acid (PFOA) in current and former residents of an exposed community. Environ Health Perspect. 2010;119(1):119-124.
51. Lee MS, Wahlqvist ML, Yu HL, Pan WH. Hyperuricemia and metabolic syndrome in Taiwanese children. Asia Pac J Clin Nutr. 2007; 16 Suppl 2:594-600.
52. Robinson R. The fetal origins of adult disease. BMJ. 2001;322(7283): 375-376.
53. Solomons NW. Programme and policy issues related to promoting positive early nutritional influences to prevent obesity, diabetes and cardiovascular disease in later life: a developing countries view. Matern Child Nutr. 2005;1(3):204-215.